$PETV
PetVivo Holdings, Inc.

2023 Q3 Form 10-Q Financial Statement

#000149315223027561 Filed on August 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2023 Q1
Revenue $207.4K $117.2K $125.6K
YoY Change -7.13% 101.44% 126.47%
Cost Of Revenue $140.9K $82.27K $102.0K
YoY Change -4.89% 55.17% 4.98%
Gross Profit $66.45K $34.91K $23.65K
YoY Change -11.54% 577.42% -156.78%
Gross Profit Margin 32.05% 29.79% 18.83%
Selling, General & Admin $2.771M $2.705M $2.122M
YoY Change 34.86% 42.38% 37.08%
% of Gross Profit 4169.13% 7746.7% 8973.53%
Research & Development $240.3K $223.8K $230.4K
YoY Change 71.16% 212.34% 23.04%
% of Gross Profit 361.58% 641.02% 974.12%
Depreciation & Amortization $30.08K $31.15K $22.64K
YoY Change 4.73% 13.05% 3.0%
% of Gross Profit 45.26% 89.22% 95.73%
Operating Expenses $3.011M $2.928M $2.353M
YoY Change 37.19% 48.56% 35.57%
Operating Profit -$2.944M -$2.894M -$2.329M
YoY Change 38.91% 47.17% 31.06%
Interest Expense -$2.440K $0.00 $0.00
YoY Change -130.58% -100.0% -100.0%
% of Operating Profit
Other Income/Expense, Net -$716.8K
YoY Change -9083.71%
Pretax Income -$3.661M -$2.894M -$2.329M
YoY Change 73.38% 47.22% 31.08%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$3.661M -$2.894M -$2.329M
YoY Change 73.38% 47.22% 31.08%
Net Earnings / Revenue -1765.55% -2469.28% -1854.28%
Basic Earnings Per Share -$0.28 -$0.25
Diluted Earnings Per Share -$0.28 -$0.25 -$0.22
COMMON SHARES
Basic Shares Outstanding 13.13M shares 11.66M shares 10.83M shares
Diluted Shares Outstanding 12.99M shares 11.66M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $55.25K $219.0K $475.3K
YoY Change -97.64% -95.0% -92.22%
Cash & Equivalents $55.25K $219.0K $475.3K
Short-Term Investments
Other Short-Term Assets $1.371M $344.3K $491.7K
YoY Change 123.91% -31.8% -10.22%
Inventory $434.1K $406.0K $370.3K
Prepaid Expenses $491.7K
Receivables $155.9K $47.11K $86.69K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.016M $1.016M $1.424M
YoY Change -40.42% -79.95% -78.92%
LONG-TERM ASSETS
Property, Plant & Equipment $665.4K $649.2K $948.8K
YoY Change 95.09% 108.68% 204.55%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $27.49K $27.49K $27.49K
YoY Change 114.26% 114.26% 114.26%
Other Assets $27.49K
YoY Change
Total Long-Term Assets $2.046M $2.083M $1.015M
YoY Change 206.51% 218.22% 51.05%
TOTAL ASSETS
Total Short-Term Assets $2.016M $1.016M $1.424M
Total Long-Term Assets $2.046M $2.083M $1.015M
Total Assets $4.062M $3.099M $2.439M
YoY Change 0.27% -45.85% -67.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $912.0K $591.9K $588.7K
YoY Change 116.05% 23.85% 82.05%
Accrued Expenses $818.4K $713.8K $858.0K
YoY Change 6.96% 5.5% 9.39%
Deferred Revenue
YoY Change
Short-Term Debt $7.140K $7.030K $6.940K
YoY Change 5.93% 5.87%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.915M $1.465M $1.454M
YoY Change 52.76% 20.02% 23.88%
LONG-TERM LIABILITIES
Long-Term Debt $16.86K $18.65K $20.42K
YoY Change -29.37% -27.01% -24.93%
Other Long-Term Liabilities $1.141M $1.217M $239.8K
YoY Change 443.82% 441.41% -0.04%
Total Long-Term Liabilities $1.158M $1.236M $260.3K
YoY Change 395.5% 393.62% -2.57%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.915M $1.465M $1.454M
Total Long-Term Liabilities $1.158M $1.236M $260.3K
Total Liabilities $3.073M $2.701M $1.714M
YoY Change 106.6% 83.61% 18.97%
SHAREHOLDERS EQUITY
Retained Earnings -$78.40M -$74.74M -$71.84M
YoY Change 16.66% 14.82% 13.81%
Common Stock $13.84K $11.83K $10.95K
YoY Change 37.12% 18.45% 9.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $988.7K $398.2K $725.0K
YoY Change
Total Liabilities & Shareholders Equity $4.062M $3.099M $2.439M
YoY Change 0.27% -45.85% -67.16%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$3.661M -$2.894M -$2.329M
YoY Change 73.38% 47.22% 31.08%
Depreciation, Depletion And Amortization $30.08K $31.15K $22.64K
YoY Change 4.73% 13.05% 3.0%
Cash From Operating Activities -$2.445M -$2.163M -$1.294M
YoY Change 19.39% 27.13% -5.49%
INVESTING ACTIVITIES
Capital Expenditures $43.62K $47.39K $130.1K
YoY Change -174.35% 90.36% -280.37%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$43.62K -$47.39K -$130.1K
YoY Change -25.65% 90.36% 80.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.956M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.329M $1.954M 1.525M
YoY Change 3483.99% -125143.31% -28821.28%
NET CHANGE
Cash From Operating Activities -2.445M -$2.163M -1.294M
Cash From Investing Activities -43.62K -$47.39K -130.1K
Cash From Financing Activities 2.329M $1.954M 1.525M
Net Change In Cash -160.1K -$256.3K 100.8K
YoY Change -92.16% -85.17% -106.97%
FREE CASH FLOW
Cash From Operating Activities -$2.445M -$2.163M -$1.294M
Capital Expenditures $43.62K $47.39K $130.1K
Free Cash Flow -$2.489M -$2.211M -$1.424M
YoY Change 25.1% 28.04% 9.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001512922
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2023Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2022Q2 PETV Consulting Services Paid In Stock
ConsultingServicesPaidInStock
usd
CY2022Q2 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
CY2022Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2023Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022Q2 PETV Increase To Operating Lease Right Of Use Asset And Operating Lease Liability
IncreaseToOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability
usd
CY2017Q2 us-gaap Lessor Operating Lease Term Of Contract
LessorOperatingLeaseTermOfContract
P84M
CY2023Q2 PETV Base Rent Payments Included In Prepaid Expenses
BaseRentPaymentsIncludedInPrepaidExpenses
usd
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity File Number
EntityFileNumber
001-40715
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
PetVivo Holdings, Inc.
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
99-0363559
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
5251 Edina Industrial Blvd.
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Edina
CY2023Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55439
CY2023Q2 dei City Area Code
CityAreaCode
(952)
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
405-6216
CY2023Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q2 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13125887 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
218978 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
475314 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
47108 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
86689 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
406030 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
370283 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
344266 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
491694 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
1016382 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
1423980 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
649235 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
630852 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1369579 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
317981 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
36511 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
38649 usd
CY2023Q2 us-gaap Security Deposit
SecurityDeposit
27490 usd
CY2023Q1 us-gaap Security Deposit
SecurityDeposit
27490 usd
CY2023Q2 us-gaap Other Assets
OtherAssets
1433580 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
384120 usd
CY2023Q2 us-gaap Assets
Assets
3099197 usd
CY2023Q1 us-gaap Assets
Assets
2438952 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
591923 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
588713 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
713772 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
779882 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
152214 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
78149 usd
CY2023Q2 PETV Notes Payable And Accrued Interest Current
NotesPayableAndAccruedInterestCurrent
7034 usd
CY2023Q1 PETV Notes Payable And Accrued Interest Current
NotesPayableAndAccruedInterestCurrent
6936 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1464943 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1453680 usd
CY2023Q2 PETV Notes Payable And Accrued Interest Non Current
NotesPayableAndAccruedInterestNonCurrent
18650 usd
CY2023Q1 PETV Notes Payable And Accrued Interest Non Current
NotesPayableAndAccruedInterestNonCurrent
20415 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1217365 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
239832 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1236015 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
260247 usd
CY2023Q2 us-gaap Liabilities
Liabilities
2700958 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1713927 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11830353 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11830353 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10950220 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10950220 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
11831 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
10950 usd
CY2023Q1 PETV Common Stock To Be Issued
CommonStockToBeIssued
137500 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
75124014 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
72420604 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-74737606 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71844029 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
398239 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
725025 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3099197 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2438952 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
117183 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
58174 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
82269 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
53020 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
34914 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
5154 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
941886 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
656569 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1762798 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1243022 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
223807 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
71656 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
2928491 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
1971247 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2893577 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1966093 usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
665 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
665 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2893577 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1965428 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2893577 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1965428 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11657035 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11657035 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9988361 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9988361 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11657035 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9988361 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
725025 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1956094 usd
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
123078 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
413030 usd
CY2023Q2 PETV Stock Issued During Period Value Vesting Of Restricted Stock Units In Lieu Of Compensation
StockIssuedDuringPeriodValueVestingOfRestrictedStockUnitsInLieuOfCompensation
74589 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2893577 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
398239 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
5986722 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
5986722 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
231231 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1965428 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
4252525 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
4252525 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2893577 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1965428 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
413030 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
231231 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
31149 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
27553 usd
CY2023Q2 PETV Investor Relations Services Paid In Stock
InvestorRelationsServicesPaidInStock
121290 usd
CY2022Q2 PETV Investor Relations Services Paid In Stock
InvestorRelationsServicesPaidInStock
45050 usd
CY2023Q2 PETV Consulting Services Paid In Stock
ConsultingServicesPaidInStock
123078 usd
CY2023Q2 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
74589 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-26138 usd
CY2022Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2205 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-39581 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2081 usd
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
35747 usd
CY2022Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
82561 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-62900 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
46742 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2163369 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1701699 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
47394 usd
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24897 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-47394 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-24897 usd
CY2023Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1956094 usd
CY2023Q2 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1667 usd
CY2022Q2 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1563 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1954427 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1563 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-256336 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1728159 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
475314 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6106827 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
218978 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4378668 usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
437 usd
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
690 usd
CY2023Q2 PETV Increase To Operating Lease Right Of Use Asset And Operating Lease Liability
IncreaseToOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability
1081204 usd
CY2023Q2 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84B_eus-gaap--UseOfEstimates_zwq05BXORqEd" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><i>(D)</i></b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><i><span id="xdx_86E_zJaQWeeHDuc2">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include collectability of accounts receivable, inventory obsolescence, estimated useful lives and potential impairment of property and equipment and intangibles, estimate of fair value of share-based payments, distributor rebate payable, provision for product returns, right of use lease assets and liabilities and valuation of deferred tax assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p>
CY2023Q2 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_847_eus-gaap--ConcentrationRiskCreditRisk_z2NBbeOyBzo1" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><i>(F)</i></b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><i><span id="xdx_864_zhvoEVwEGDbk">Concentration Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The Company maintains its cash with various financial institutions, which at times may exceed federally insured limits. At March 31, 2023, the Company did have cash balances in excess of the federally insured limits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p>
CY2023Q2 PETV Distribution Fee Payable Percentage
DistributionFeePayablePercentage
0.05 pure
CY2023Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
35568 usd
CY2023Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
81510 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
28000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
28000 usd
CY2023Q2 PETV Distribution Fee Payable
DistributionFeePayable
3964 usd
CY2023Q1 PETV Distribution Fee Payable
DistributionFeePayable
5187 usd
CY2023Q2 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
0 usd
CY2023Q1 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
0 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
406030 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
370283 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
27473 usd
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
13159 usd
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
76011 usd
CY2023Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
53398 usd
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
302546 usd
CY2023Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
303726 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
406030 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
370283 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
344266 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
491694 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
987536 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
940142 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
338301 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
309290 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
649235 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
630852 usd
CY2023Q2 us-gaap Depreciation
Depreciation
29011 usd
CY2022Q2 us-gaap Depreciation
Depreciation
25326 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
170682 usd
CY2023Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
3870057 usd
CY2023Q1 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
3870057 usd
CY2023Q2 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
26142 usd
CY2023Q1 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
26142 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3896199 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3896199 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3859688 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3857550 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
36511 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
38649 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2138 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2227 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
258978 usd
CY2023Q2 PETV Accrued Expenses Current
AccruedExpensesCurrent
210852 usd
CY2023Q1 PETV Accrued Expenses Current
AccruedExpensesCurrent
188666 usd
CY2023Q2 PETV Accrued Lease Termination Expense
AccruedLeaseTerminationExpense
332238 usd
CY2023Q1 PETV Accrued Lease Termination Expense
AccruedLeaseTerminationExpense
332238 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
713772 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
779882 usd
CY2023Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
332000 usd
CY2023Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
332000 usd
CY2020Q1 us-gaap Notes Payable
NotesPayable
42500 usd
CY2020Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.06 pure
CY2023Q2 us-gaap Notes Payable
NotesPayable
25684 usd
CY2023Q1 us-gaap Notes Payable
NotesPayable
27351 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
7034 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
18650 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
6936 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
20415 usd
CY2023Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
12554 usd
CY2022Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
6158 usd
CY2017Q2 us-gaap Area Of Land
AreaOfLand
3577 sqft
CY2017Q2 PETV Percentage Of Increase In Rent
PercentageOfIncreaseInRent
0.02 pure
CY2020Q1 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
In January 2020, the Company entered into a lease amendment to extend the lease term through November of 2026
CY2020Q1 us-gaap Notes Payable
NotesPayable
42500 usd
CY2023Q2 PETV Base Rent
BaseRent
2294 usd
CY2023Q1 PETV Base Rent
BaseRent
2294 usd
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
70792 usd
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
35435 usd
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
195000 shares
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
152410 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
207061 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
211002 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
187717 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
121165 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
114273 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
518517 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1512145 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
142566 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1369579 usd
CY2023Q2 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
the extended lease terms to June 2026, November 7, 2026, March 2027, and June 2033
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y1M6D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0394 pure
CY2023Q2 PETV Operating Lease Liability Gross
OperatingLeaseLiabilityGross
1369579 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1369579 usd
CY2023Q2 PETV Operating Lease Rightofuse Current Asset
OperatingLeaseRightofuseCurrentAsset
1369579 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1369579 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
152214 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1217365 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1369579 usd
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.56
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M24D
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2893577 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2163369 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-74737606 usd
CY2023Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
793585 shares
CY2023Q2 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
2182359 usd
CY2023Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
88765 usd
CY2023Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
2.75
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
137500 usd
CY2023Q2 PETV Amortization Of Prepaid Stock Issued For Services
AmortizationOfPrepaidStockIssuedForServices
121290 usd
CY2022Q2 PETV Amortization Of Prepaid Stock Issued For Services
AmortizationOfPrepaidStockIssuedForServices
45050 usd
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.849 pure
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.932 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.117 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.469 pure
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0346 pure
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0389 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0296 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0435 pure
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
100200 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
714849 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.37
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
25000 shares
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.46
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
884849 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.19
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y3M18D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
307750 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
374239 shares
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.30
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1259088 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.22
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y3M18D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
86300 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
192122 shares
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
709394 shares
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
195000 shares
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1066966 shares
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
709394 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
192122 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
175455 shares
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
2.23
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.56
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
2.26
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
2.23
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1.99
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
2.01
CY2023Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0 usd
CY2022Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
413030 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
231231 usd

Files In Submission

Name View Source Status
0001493152-23-027561-index-headers.html Edgar Link pending
0001493152-23-027561-index.html Edgar Link pending
0001493152-23-027561.txt Edgar Link pending
0001493152-23-027561-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
petv-20230630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
petv-20230630_cal.xml Edgar Link unprocessable
petv-20230630_def.xml Edgar Link unprocessable
petv-20230630_lab.xml Edgar Link unprocessable
petv-20230630_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending